Sign Out
Known hypersensitivity to meloxicam or any excipient of the product.
Use in patients who have developed signs of asthma, nasal polyps, angio-oedema or urticaria following the administration of acetylsalicylic acid or other non-steroidal anti-inflammatory drugs (NSAIDs), because of a potential for cross sensitivity.
Peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.
Active or recent gastro-intestinal ulceration/perforation.
Active inflammatory bowel disease (Crohn's Disease or Ulcerative Colitis).
Severe hepatic insufficiency.
Non-dialysed severe renal insufficiency.
Overt gastro-intestinal bleeding, recent cerebrovascular bleeding or established systemic bleeding disorders.
Severe uncontrolled heart failure.
Pregnancy or breastfeeding.
Rare hereditary conditions that may be incompatible with an excipient of the product (see Precautions).
